Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-06-16

Interference of anthracyclines with cardiac energy signalling: implications for drugs, cardiotoxicity and oncogenic growth

Obiettivo

Anthracyclines belong to the most efficient drugs of cancer chemotherapy. However, their use is limited by severe cardiotoxicity, whose molecular triggers are not fully understood. Our aim is to analyse novel aspects of cardiac response to anthracyclines, namely signalling pathways regulating cardiac energetics. The ability to respond to altered energy supply or demand is particularly important for heart to maintain its contractile performance. Our approach will integrate a non-biased global analysis of antracycline-induced changes in gene expression and proteome/phospho-proteome with a targeted analysis of the signaling pathway of AMP-activated protein kinase (AMPK).

AMPK is a key sensor and regulator of cellular energy state and the drug reduces basic AMPK phosphorylation as we showed recently. The multidisciplinary approach combining biophysical, biochemical, molecular and physiological state-of-the-art techniques will (i) apply different model systems as recombinant protein, cultured cardiomyocytes, isolated perfused rat heart, and cancer cells for comparison, (ii) explore regulatory cross-talk between the AMPK cascade and other signalling pathways or key regulators of cardiac energy metabolism (e.g. creatine kinase), (iii) screen a library of cardioprotective compounds.

In scientific terms, we will identify anthracycline-induced changes in the cardiac energetic network and other signalling pathways susceptible to mediate drug cardiotoxic, and possibly anticancer effects. This can provide potent means to modulate drugs toxic and therapeutic activity. In terms of training, fellows goal is to acquire expertise in different cardiac models and in integrative approach (from molecular to physiological) to cardiac bioenergetics and non-scientific skills in a leading medically oriented research environment to amend her multidisciplinary portfolio with the long-term goal to obtain a permanent, leading position in research, e.g. as professor or clinical researcher.

Campo scientifico (EuroSciVoc)

Parole chiave

Argomento(i)

Invito a presentare proposte

FP6-2005-MOBILITY-5
Vedi altri progetti per questo bando

Meccanismo di finanziamento

EIF - Marie Curie actions-Intra-European Fellowships

Coordinatore

UNIVERSITE JOSEPH FOURIER GRENOBLE 1
Contributo UE
Nessun dato
Costo totale
Nessun dato